ftInvstr
ANTHEM · Healthcare ₹959.0 +1.77% Mkt Cap ₹53966 Cr fair

ANTHEM

Healthcare Biotechnology
₹959.0
+1.77% today · 30d +10.75%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for ANTHEM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹594 Cr
+8.0% YoY
NET PROFIT
₹211 Cr
+21.93% YoY
OPM
50.6%
+6.12pp YoY
EPS
₹3.75
PE 88.49
Intrinsic value · DCF ₹835.23 · Margin of safety -12.9% (fair) · FCF yield 1.17%
◇ Sector Position
PEERPEROCE %
ANTHEM88.4930.0
BIOCON175.486.88
ONESOURCE—4.57
CONCORDBIO44.9320.36
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation STRETCHED 20
Growth STRONG 72
Profitability HIGH 100
Technicals NEUTRAL 60
Risk LOW 90
Key Stats
TTM PE
88.49
P/B
16.46
52W HIGH
₹989.1
OFF HIGH
-3.04%
DIV YIELD
0.21%
MKT CAP
₹53966 Cr
◉ Active Signals
MACDBullish16.4353
RSI(14)Bearish73.83
Near 52W HighBullish-3.04
Street Consensus
8 analysts
₹974.25
mean target
Low ₹850.0Now ₹959.0High ₹1063.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ANTHEM and at what entry.

Sign up freeSign in